Rockville, MD August 01, 2022 –( PR.com )– Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, is excited to welcome Albert J. Steren, MD, FACOG, to their team in August. With over 30 years of experience and board certified in gynecologic oncology, Dr. Steren will be seeing patients at the Aquilino Cancer Center in Rockville, located at 9905 Medical Center Drive, Suite 200, Rockville, MD, 20850.
Dr. Steren is a leader in minimally invasive gynecological surgery, and in 2008, he performed the first robotic surgery in Montgomery County. This accomplishment, as well as the rest of his distinguished career, has been recognized by numerous distinctions and awards, including being named to Newsweek’s list of top oncologists. He has also received top doctor distinctions from Washingtonian magazine, Bethesda magazine, and U.S. News & World Report.
“We are so excited to have Dr. Steren join the team at Maryland Oncology Hematology,” said Dr. George Sotos, MOH Practice President. “He has been a leading cancer surgeon in our region for decades. We are fortunate that he is bringing his skill and expertise in leading-edge treatments for gynecologic cancer to our community.”
Dr. Steren received his medical degree from George Washington University before completing his internship and residency at Johns Hopkins Hospital and his fellowship at the University of Miami Jackson Memorial Medical Center. He comes to MOH from Women’s Health Specialists of Montgomery County, where he has practiced for the past 20 years. Dr. Steren is also an associate clinical professor at Uniformed Services University of the Health Sciences, and an assistant clinical professor at George Washington University School of Medicine. “I’m thrilled to be joining the practice at the Aquilino Cancer Center,” said Dr. Steren. “I look forward to continuing my work with the community in Rockville.”
To learn more or to schedule an appointment, visit MarylandOncology.com or call 301-424-6231.
About Maryland Oncology Hematology
Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.
About US Oncology Network
Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.
Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, has elected George Sotos, MD as the new practice President. Dr. Sotos succeeds Dr. Joseph Haggerty as of June 1 and will serve a three-year term.
Dr. Sotos practices in the Rockville Division with offices in Germantown, Bethesda, and at the Aquilino Cancer Center in Rockville. He is board-certified in internal medicine and medical oncology. After earning a Bachelor of Arts degree in Computer Science from Dartmouth College and a Master’s degree in Physiology from Georgetown University, he attended medical school at the Medical College of Virginia. He completed his internship and residency in internal medicine at the University of Texas Southwestern Medical Center/Parkland Memorial Hospital, and his fellowship in medical oncology at the National Institutes of Health. Dr. Sotos has been actively involved at Suburban Hospital serving as chair of the hematology and oncology subsection for 22 years, on the medical executive committee for 12 years, and as the coordinator of the neuro/aerodigestive, gastrointestinal and genitourinary multidisciplinary tumor boards for 11 years. Most recently, he served on the MOH Board from 2018 to 2022, and as the Managing Partner of the Rockville Division from 2019 to 2022.
Dr. Sotos was named a Top Doctor by Bethesda Magazine in 2021 and 2019, and consistently by the Washingtonian over the last twenty years. He is affiliated with the American College of Physicians, Montgomery County Medical Society, Medical and Chirurgical Faculty of the State of Maryland, American Society of Clinical Oncology, and the American Medical Association.
About Maryland Oncology Hematology
Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH provides expertise in medical oncology and hematology, surgery for breast, colorectal and gynecologic malignancies, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH takes pride in providing state-of-the-art cancer therapies in a community setting, close to patients’ homes and support systems. Our physicians are supported by a talented clinical and administrative team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.
About US Oncology Network
Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,200 dedicated, independent physicians nationally who share resources and expertise to deliver integrated care and better outcomes to patients — close to home. The Network is supported by McKesson Corporation whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.
Media Inquiries
Maryland Oncology Hematology
Mark W. Lamplugh Jr.
561-7629-729
marylandoncology.com
Dr. Sethi has over 18 years of experience, specializing in targeted and biological therapy.
Maryland, 3/24/2022 – Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, has added Harminder Sethi, MD, to their hematology and medical oncology team. Dr. Sethi specializes in treatment plans that include targeted and biological therapy designed to treat the unique intricacies of each patient’s illness. “Dr. Sethi will see patients at the Hyattsville office located at 6505 Belcrest Rd, Hyattsville, MD 20782, as well as the White Oak Cancer Center at 11886 Healing Way Suite 701, Silver Spring, MD, 20904 once a week. Upon its opening, he will also see patients at the DC office located at 1140 Vamum St. NE in Washington, DC.
Dr. Sethi completed his initial medical education in India before finishing his residency at North Shore University Hospital, NY followed by a fellowship in oncology/hematology at Medstar Washington Hospital Center. During his fellowship, Dr. Sethi completed bone marrow transplant training in affiliation with the Fred Hutchinson Cancer Center in Seattle, WA, and additional oncology training with the National Heart, Blood, and Lung Institute. Dr. Sethi has ardent respect for his patients and develops treatment plans that include targeted therapy and biological therapy based on the most up-to-date national guidelines tailored to each patient’s particular circumstances and goals.
“I’m thrilled to join the team at Maryland Oncology Hematology to serve patients throughout our community,” said Dr. Sethi, hematology and medical oncologist, MOH. “Through our access to the latest technology and groundbreaking treatments, I’m happy to bring patients new hope in fighting cancer.”
“Dr. Sethi is an excellent addition to MOH,” said Joseph Haggerty, MOH Practice President. “His impressive experience in both hematology and medical oncology will provide a great benefit to the local community.”
To learn more or to schedule an appointment, visit MarylandOncology.com or call (301) 779-8800.
About Maryland Oncology Hematology
Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.
About US Oncology Network
Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,400 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.
Dr. Barter is an accomplished surgeon and clinical researcher who will provide state-of-the-art treatments and minimally invasive surgical options to patients in the region.
Maryland, 3/15.2022 – Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, has added Dr. James Barter, MD, FACOG to their gynecologic oncology and surgical team at White Oak Cancer Center. Dr. Barter is experienced in minimally invasive surgeries and has performed more than 1,700 robotic surgeries and procedures.
Dr. Barter joins Maryland Oncology Hematology at The White Oak Cancer Center. Dr. Barters’ current interests include surgery using the Da Vincia surgical robot to assist in gynecologic surgery. He is ranked in the top 15 users worldwide for robotic gynecologic and gynecologic oncology procedures and has lectured both locally and internationally on the topic. Along with his extensive research with Dr. David Min and the HCSS research division, Dr. Barter has activated and overseen clinical trials with over 1,300 patients entered in protocols since 2006.
“I’m looking forward to partnering with Maryland Oncology Hematology to provide leading-edge, research–based, and patient-centered care to the community,” said Dr. Barter, a gynecologic surgeon at White Oak Cancer Center. “With a firm understanding of the latest treatment advances and surgical techniques, I hope to bring patients new cancer care options.”
Dr. Barter is recognized as one of the country’s leading gynecologists by Good Housekeeping, perennially as one of the Top Doctors in the Washington, D.C. area, as well as one of only two gynecologic oncologists noted as top doctors in Northern Virginia. He is currently a clinical professor at George Washington University and director of gynecologic oncology research at Holy Cross Hospital. He received his medical degree from the University of Virginia and completed two years of internal medicine and four years of obstetrics and gynecology at Duke University Medical Center, followed by a fellowship in gynecologic oncology at the University of Alabama Medical Center. He was at Lombardi Cancer Center/ Georgetown University Medical Center for 16 years, rising to the rank of professor.
His four-year interest in the development of a serum blood test for ovarian cancer detection will soon culminate in published research involving serum proteomics. In conjunction with Holy Cross, Dr. Barter continues his interest in protocols dealing with novel approaches for ovarian cancer treatment, having received research grants.
“We’re thrilled to have Dr. Barter join our team of talented surgeons at Maryland Oncology Hematology” said Kashif Firozvi, MD, Director at White Oak Cancer Center. “His background in research and clinical trials, as well as his impressive experience in both gynecologic oncology and surgery will be of great benefits to the local community.”
White Oak Cancer Center is located at 11886 Healing Way Suite 101, Silver Spring, MD, 20904. To learn more or to schedule an appointment, visit MarylandOncology.com or call 301.343.3892.
About Maryland Oncology Hematology
Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.
About US Oncology Network
Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,400 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.
The ASCO’s Board of Directors is comprised of oncology leaders who are elected to positions reflecting various specialties within the oncology field.
Bethesda, MD (January 2022) — Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, announced today that medical oncologist Carolyn Hendricks, MD, FASCO has been named to the Board of The American Society of Clinical Oncology. Dr. Hendricks was elected to the Designated Community Oncologist seat and will begin a four-year term starting in June 2022.
Dr. Hendricks is a medical oncologist specializing in breast cancer genetics, screening, and treatment at Maryland Oncology Hematology. She has served on a number of ASCO committees, including as chair of the ABIM-ASCO Breast Cancer Exam Subcommittee, chair-elect of the Practice Quality Improvement Steering Group, past chair of the Government Relations Committee, and a member of Clinical Practice Committee and the Quality Training Program Steering Group, among another volunteer service. Dr. Hendricks was honored as Advocate of the Year by the Association for Clinical Oncology in 2019.
Dr. Hendricks specializes in breast cancer and is an active member of a multidisciplinary team focused on breast cancer genetics, screening, and treatment. She provides leading-edge and comprehensive treatment at the local level. Praised for her involvement in clinical trials for breast cancer, she brings knowledge and support to community groups by providing education about breast cancer.
Her greatest accomplishments include her ASCO (American Society of Clinical Oncology) volunteer activities both nationally and internationally in the area of quality cancer care. She received the prestigious ASCO Fellowship Award in June 2018. Dr. Hendricks is also known for heightening breast cancer awareness and delivering quality breast cancer care throughout her career.
“We are thrilled to congratulate Dr. Hendricks on this incredible achievement,” said Joseph M. Haggerty, M.D, Practice President at Maryland Oncology Hematology. “With her focus on promising new advancements in breast cancer treatment and her commitment to providing education throughout the community, Dr. Hendricks is integral in delivering comprehensive and expert care to our breast patients.”
Dr. Hendricks is currently seeing patients at MOH’s Bethesda location. Immediate appointments are available for newly referred patients to provide a high level of support and prompt access to care. Please call 301.424.6231 to make an appointment.
About Maryland Oncology Hematology
Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.
About US Oncology Network
Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,380 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. MOH also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.
To be distributed to local media:
Practice: Maryland Oncology Hematology
Contact: Mark Lamplugh
Phone: 561-762-9729
Email: mark.lamplugh@usoncology.com
Dr. Magnant joins Dr. Surupa Sen Gupta at their Rockville Division to offer the community advanced surgical care with the latest breast preservation techniques.
Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, is proud to announce that Dr. Colette Magnant, MD, FACS is joining its Rockville division.
Dr. Magnant has been treating breast cancer for over 34 years and has established herself as one of the premier breast cancer surgeons in the Washington, D.C. metropolitan area. With her extensive training and wealth of experience, she provides her patients with a superior understanding of breast cancer biology, as well as compassionate state of the art breast preservation procedures, and advanced surgical techniques. She will be joining Dr. Surupa Sen Gupta to expand our breast surgical oncology services at our Rockville division, and together they, along with our expert and experienced medical oncologists, will anchor our comprehensive breast cancer program in the Rockville division.
‘We’re thrilled to welcome Dr. Magnant to our experienced breast surgical team. Her stellar reputation as a top breast surgeon is well-deserved and we are fortunate that she has decided to bring her skills to our practice and to our community. She shares our vision of providing state-of-the-art multidisciplinary cancer care, and we are delighted to have her join in our expansion said George Sotos MD, Managing Partner, Rockville Division. ‘With her focus and strong surgical experience in breast cancer treatment, Dr. Magnant is a welcome addition to our team as we dedicate our practice to delivering the very best in comprehensive and integrated care to our breast cancer patients.
Dr. Magnant is board certified in general surgery, specializing in advanced breast surgery techniques, including skin and nipple-sparing mastectomies and minimally invasive breast conserving surgeries. After earning her medical degree from the Medical College of Virginia in Richmond, Dr. Magnant completed her general surgery internship at Indiana University Medical Center and her residency at Georgetown University Hospital in Washington, DC. She is most recently the past director of the Sullivan Center for Breast Health at Sibley Hospital, as well as an assistant professor at John Hopkins University. In addition to teaching, Dr. Magnant has made numerous media appearances and delivered dozens of university lectures.
‘I’m proud to work alongside the dynamic team at Maryland Oncology Hematology, said Dr. Magnant. ‘We’re dedicated to delivering compassionate and comprehensive breast health services to the surrounding community, allowing our patients to receive the best of care, close to home.
Dr. Magnant will be joining Dr. Sen Gupta who is board certified in general surgery, fellowship trained in breast surgical oncology, and specializes in minimally invasive breast-conserving surgeries.
Dr. Magnant will start seeing patients at MOH’s Rockville office on April 1st. Appointments are available for newly referred patients to provide a high level of support and easy access to care. Please call 301.424.6231 to make an appointment.
About Maryland Oncology Hematology
Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.
About US Oncology Network
Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,380 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation , whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. MOH also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.
Media Contact Company Name: Maryland Oncology Hematology Contact Person: Mark W Lamplugh Jr Email: Send Email Phone: 5617629729 Country: United States Website: https://mdoncology.wpengine.com
Dr. Plate brings a new line of treatment services to the clinic, offering patients cutting-edge breast preservation techniques
Silver Spring, MD- November, 2020— Maryland Oncology Hematology, the premier provider of cancer services in the Maryland region, announced today it has added a breast surgical oncologist to the practice, enhancing the comprehensive multidisciplinary care it provides to breast patients. Cynthia Plate M.D. F.A.C.S specializes in breast surgery and has extensive training and experience in the field. MOH has been serving cancer patients in the Maryland area for over 40 years, providing patients convenient access to leading cancer experts and the most advanced cancer therapies available today.
Dr. Plate has many years of rigorous education, training, and experience focusing on breast disease and surgery, providing her with a superior understanding of breast cancer biology, genetics, and advanced oncoplastic surgical techniques and breast preservation procedures. By adding Dr. Plate to the practice, MOH’s new White Oak Cancer Center enhances its ability to offer multidisciplinary team care for all types of complex breast issues, including benign breast disease, malignancies, and management of high-risk patients. Seamless high-quality care is provided by a collaborative team of specialists in breast surgery, medical and radiation oncology, diagnostic imaging, pathology, genetic risk evaluation, and supportive care.
“Dr. Plate shares our passion of providing exceptional multidisciplinary cancer care, and we are delighted to have her join our growing practice” said Dr. Joseph Haggerty, President at Maryland Oncology Hematology. “With her focus on new surgical advancements in breast cancer treatment, Dr. Plate will be a great addition to our breast cancer team as we seek to deliver the best breast cancer treatment in the Maryland Region.”
Cynthia Plate M.D. F.A.C.S is board-certified in general surgery and is a breast care specialist. She previously worked with Adventist HealthCare Medical Group.
Dr. Plate graduated from Howard University College of Medicine and completed her internship and residency at Howard University Hospital
“Specializing in women’s breast health, I’m committed to providing my patients with exceptional and compassionate care,” said Dr. Plate. “I’m thrilled to join the MOH team where we can continue to deliver leading-edge cancer care to our community.”
Dr. Plate is currently seeing patients at MOH’s Silver Spring White Oak Cancer Center office. Timely appointments are available for newly referred patients, typically within 24 hours, to provide a high level of support and prompt access to care. Please call 301-933-3216 to make an appointment
About Maryland Oncology Hematology
Maryland Oncology Hematology is an affiliate of The US Oncology Network (The Network). This
collaboration unites MOH with more than 1,400 independent physicians dedicated to delivering value-based, integrated care for patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The US Oncology Network is supported by McKesson Specialty Health, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. MOH participates in clinical trials through US Oncology Research, which has played a role in more than 70 FDA-approved cancer therapies, approximately one-third of all cancer therapies approved by the FDA to date. For more information, visit www.usoncology.com.
About US Oncology Network
Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.
MOH’s new state-of-the-art facility will provide community cancer care to patients throughout the Annapolis area.
Beltsville, MD (10/28/20) – Maryland Oncology Hematology (MOH), a 48-physician privately-owned practice specializing in the diagnosis and treatment of cancer, announced it is opening its 13th location in Annapolis, MD. This new state-of-the-art facility will allow patients in Annapolis and the surrounding areas to access high-quality cancer care in a convenient community setting close to home. Maryland Oncology Hematology is now accepting appointments and will start seeing patients at the Annapolis office beginning November 2nd.
“With the opening of this new office, MOH will be providing the highest quality cancer care to the Annapolis community,” said Joseph Haggerty MD, Practice President, Maryland Oncology Hematology. “Patients will be able to receive leading-edge cancer care without having to travel long distances.”
Maryland Oncology Hematology in Annapolis will provide advanced care and comprehensive services including medical oncology, hematology, genetic risk assessment, and clinical research. Working as an independent practice allows MOH physicians the freedom to tailor care to each patient’s unique diagnosis. With one of the largest and most active clinical research programs conducted by a private practice in the state, MOH offers to its patients, among other things, the opportunity to participate in Phase I-IV clinical trials.
The multi-disciplinary team at the Annapolis location will deliver the latest in advanced, integrative cancer treatment. MOH is proud to announce that the following physicians will provide care at the new office:
Ravin J. Garg, MD
Peter R. Graze, MD
Stuart E. Selonick, MD
Jason D. Taksey, MD
Jeanine L. Werner, MD
MOH is further pleased to announce that Benjamin Bridges, MD, Adam J. Goldrich, MD, Carol K. Tweed, MD, and David E. Weng, MD will also be joining its team. These physicians will be temporarily practicing out of MOH’s office in Clinton, Maryland.
The MOH Annapolis office is located at 810 Bestgate Rd, Suite 400, Annapolis, MD, 21401. Physicians, patients, and family members can call 410.897.6200 to arrange a visit, consultation, or to make an appointment. The MOH Clinton office is located at 8926 Woodyard Rd #101 Clinton, MD 20735. Physicians, patients, and family members can call 301-812-3900 arrange a visit, consultation, or to make an appointment.
About Maryland Oncology Hematology
Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 48 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in oncology & hematology services, cancer genetic risk assessment, clinical trials and research. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.
Maryland Oncology Hematology is Partnering with Adventist HealthCare to Offer Comprehensive Care that Includes Advanced Radiation Services at the White Oak Cancer Center
Dr. Luqman Dad will lead The Center of Advanced Radiation Oncology and provide state-of-the-art radiation services and technologies to patients in the region.
Maryland, October 20, 2020 – Maryland Oncology Hematology (MOH), the largest independent oncology practice in Maryland and a member of The US Oncology Network, has partnered with Adventist HealthCare to open The Center for Advanced Radiation Oncology at White Oak Cancer Center.
Led by radiation oncologist Luqman Dad, MD, the Center for Advanced Radiation Oncology at White Oak will work alongside the team at Maryland Oncology Hematology to offer compassionate, patient-centered, state-of-the-art radiation therapy. The center will offer seamless delivery of high-quality precise treatment by expert specialists, providing some of the latest in techniques and technologies, including: SBRT, IMRT, IGRT, SRS, and Brachytherapy, along with access to hyperbaric oxygen chamber for late toxicities and radiosensitization of recurrent tumors. The Center for Advanced Radiation Oncology will be located in the White Oak Cancer Center, where patients can have access to a comprehensive multidisciplinary approach to cancer including medical oncology/hematology, radiation oncology, surgical oncology, PET/CT imaging, genetics, research, nutrition, palliative care, social work, physical, occupational and speech rehabilitation.
Dr. Dad brings years of leadership and academic study to The Center of Advanced Radiation Oncology at White Oak Cancer Center. Born at the original Washington Adventist Hospital, Dr. Dad grew up just down the road from the White Oak Cancer Center and attended Paint Branch High School. He completed his undergraduate and medical studies at Boston University. In 2011, Dr. Dad returned to Maryland following the completion of his post-graduate training in Radiation Oncology at Roswell Park Cancer Institute. The Washington Metropolitan area remains close to his heart.
Medical Director, Radiation Oncology
“I’m proud to live in a community with great culture, diversity, and opportunities where we can make a tremendous impact and deliver top-notch cancer care,” said Dr. Dad, Medical Director at The Center for Advanced Radiation at White Oak. “At The Center for Advanced Radiation, we’re excited to provide personalized, innovative cancer treatments using the latest technologies.”
Dr. Luqman Dad serves as the Medical Director at The Center for Advanced Radiation Oncology at White Oak. He performs numerous procedures to treat patients at all stages of cancer care and is skilled in advanced radiation techniques, including stereotactic body radiation therapy (SBRT), intracranial radiosurgery (SRS), proton beam therapy, gynecologic high-dose rate (HDR) brachytherapy, and more. He is board certified in radiation oncology.
Through the affiliate partnership with the Maryland Proton Treatment Center (MPTC), Dr. Dad has access to this new advanced treatment that is only available in select cancer centers nationwide. Dr. Dad is able to see patients at the White Oak Cancer Center and collaborate with the team at MPTC if proton beam treatment is indicated for the patient.
Dr. Dad has a special interest in breast, prostate, lung, head and neck, gastrointestinal, lymphoma, and central nervous system malignancies. He has served as a lead physician in helping develop national clinical practice parameters for SBRT, as well as principal investigator on industry-sponsored clinical trials. Dr. Dad is an active member of the American Society for Radiation Oncology (ASTRO), where he serves on national committees and helps ASTRO in the global outreach of radiation oncology to underserved regions of the world.
“I’m looking forward to the opportunity to partner with Maryland Oncology Hematology to provide cutting-edge, evidence–based, patient-centered care to this community,” said Dr. Dad. “I believe that the dynamic location, supported by strong infrastructure and the future vision for the White Oak corridor as a hub for science and technology that will place The White Oak Radiation Oncology Program in a position for tremendous growth and success.”
Opening in November, The Center for Advanced Radiation Oncology at White Oak Cancer Center will be located at 11886 Healing Way Suite 101, Silver Spring, MD, 20904. To learn more or to schedule an appointment, visit MarylandOncology.com or call 301.343.3892.
About Maryland Oncology Hematology
Maryland Oncology Hematology (MOH) is the largest independent oncology practice in the state of Maryland, with more than 45 practicing clinicians devoted exclusively to providing comprehensive, compassionate, and high-quality cancer care. MOH specializes in medical, gynecologic, hematology, cancer genetic risk assessment, clinical trials and research, and patient ancillary programs. MOH believes it is beneficial to provide cancer therapies in a community setting, close to patients’ homes and support systems. The physicians are supported by a talented clinical team sensitive to the needs of cancer patients and their caregivers. For more information, visit MarylandOncology.com.
About US Oncology Network
Maryland Oncology Hematology is a practice in The US Oncology Network (The Network). This collaboration unites the practice with more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. Maryland Oncology Hematology also participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies.
